Algo version: 0.98b
HLS THERAPEUTICS INC is listed at the TSX Exchange
HLS THERAPEUTICS INC [HLS.TO]
TSX Sector: Industry:Drug Manufacturers—Specialty & Generic

Is HLS THERAPEUTICS INC stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, HLS THERAPEUTICS INC pays dividends. Last time was Thursday 15th of June 2023 where the investors holding the stock on Thursday 27th of April 2023 were paid $0.05 per share. Over the last 18 times between 2019 and 2023, HLS THERAPEUTICS INC has paid $0.9 with an average of $0.05 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for HLS THERAPEUTICS INC 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $14.35, you would have made a loss of $-11.15 per share or -77.70%

No, the average daily trading liquidity for HLS THERAPEUTICS INC is $52 072 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

HLS THERAPEUTICS INC has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.15, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for HLS THERAPEUTICS INC to be high [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.